CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 82.12% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money
93.21
1.4%
Market Trading Hours* (UTC) Opens on Tuesday at 14:30

Tue - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
Trading сonditions
Spread 0.35
Long position overnight fee

Long position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment -0.023346 %
Charges from full value of position ($-4.44)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.023346%
Short position overnight fee

Short position overnight funding adjustment


Margin. Your investment $1,000.00
Overnight funding adjustment 0.001124 %
Charges from full value of position ($0.21)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.001124%
Overnight fee time 22:00 (UTC)
Min traded quantity 0.1
Currency USD
Margin 5.00%
Stock exchange United States of America
Commission on trade 0%

Key Stats
Prev. Close 91.92
Open 92.5
1-Year Change -75.82%
Day's Range 92.35 - 93.66
  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Jan 16, 2025 91.92 1.94 2.16% 89.98 92.46 89.82
Jan 15, 2025 90.56 1.06 1.18% 89.50 91.13 89.15
Jan 14, 2025 88.94 -1.45 -1.60% 90.39 91.23 88.48
Jan 13, 2025 91.16 2.27 2.55% 88.89 91.95 88.58
Jan 10, 2025 90.23 -0.12 -0.13% 90.35 91.61 89.33
Jan 8, 2025 91.77 -0.21 -0.23% 91.98 92.25 91.04
Jan 7, 2025 92.44 -0.59 -0.63% 93.03 94.76 92.17
Jan 6, 2025 92.95 2.40 2.65% 90.55 93.26 90.55
Jan 3, 2025 91.64 1.27 1.41% 90.37 91.82 90.08
Jan 2, 2025 90.50 -1.16 -1.27% 91.66 92.45 90.30
Dec 31, 2024 91.80 0.32 0.35% 91.48 92.42 90.57
Dec 30, 2024 91.28 0.02 0.02% 91.26 92.19 90.45
Dec 27, 2024 92.20 0.76 0.83% 91.44 92.69 91.13
Dec 26, 2024 92.47 0.55 0.60% 91.92 92.57 91.67
Dec 24, 2024 92.60 1.51 1.66% 91.09 92.73 91.09
Dec 23, 2024 92.27 -0.04 -0.04% 92.31 93.00 91.77
Dec 20, 2024 93.33 1.70 1.86% 91.63 94.62 91.57
Dec 19, 2024 91.85 -0.36 -0.39% 92.21 92.38 91.12
Dec 18, 2024 92.11 -2.01 -2.14% 94.12 94.77 92.10
Dec 17, 2024 94.37 1.04 1.11% 93.33 96.25 93.26

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 3:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Cooper Company profile

About Cooper Companies Inc

The Cooper Companies, Inc. is a global medical device company. The Company operates through two segments: CooperVision and CooperSurgical. The CooperVision segment is engaged in developing, manufacturing, and marketing a range of products for contact lens wearers, featuring advanced materials and optics. CooperVision designs its products to solve vision challenges such as astigmatism, presbyopia, myopia, ocular dryness, and eye fatigues, with a collection of spherical, toric and multifocal contact lenses. The CooperSurgical segment is focused on advancing the health of women, babies, and families through a diversified portfolio of products and services including medical devices, fertility, diagnostics and contraception. CooperSurgical's products are used in medical office and surgical procedures, primarily by obstetricians/gynecologists (OB/GYN); and fertility products/equipment and genetic testing services used primarily in fertility clinics and laboratories.

Financial summary

BRIEF: For the three months ended 31 January 2022, Cooper Companies Inc revenues increased 16% to $787.2M. Net income decreased 95% to $95.3M. Revenues reflect CooperVision segment increase of 11% to $561.5M, CooperSurgical segment increase of 30% to $225.7M, United States segment increase of 17% to $365.3M, Europe segment increase of 13% to $250.4M, Rest of the World segment increase of 17% to $171.5M.

Equity composition

Common Stock $.10 Par, 1/11, 70M auth., 46,473,000 issd., less 282,000 shs. in Treas. @ $4.3M. Insiders & Strategic Owns 0.70%. PO7/97,2M shs. @ $23.50 by Deutsche Morgan Grenfell. 11/02, 2-for-1 split; 9/95, 1-for-3 reverse stock split. FY'05 Qs are being restated. Summ. Q's reflect RES for FY'05.

Industry: Glasses, Spectacles & Contact Lenses

6101 Bollinger Canyon Road
Suite 500
SAN RAMON
CALIFORNIA 94583
US

People also watch

XRP/USD

3.28 Price
-0.770% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 0.01636

ETH/USD

3,479.77 Price
+4.750% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 1.75

BTC/USD

104,397.80 Price
+4.280% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 50.00

US100

21,441.70 Price
+1.820% 1D Chg, %
Long position overnight fee -0.0233%
Short position overnight fee 0.0011%
Overnight fee time 22:00 (UTC)
Spread 7.0

Still looking for a broker you can trust?

Join the 660,000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading